Skin Biophysical PropertiesNCT07458334
Skincare Benefits of Kaempferol-Containing Masks
A study testing Kaempferol-containing facial mask and Hyaluronic acid-containing facial mask in people with Skin Biophysical Properties, run by Kaohsiung Medical University Chung-Ho Memorial Hospital at 1 site in Taiwan.
Trial summary
This is an open-label, two-arm study, which will evaluate the effects of Kaempferol-containing masks on skin biophysical properties Read more about this study
- Who is it for?
- Ages 25 to 60 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Skin Biophysical Properties
- What is being tested?
- Kaempferol-containing facial mask and Hyaluronic acid-containing facial mask
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTaiwan
- Study dates
- 9 Feb 2026to Mar 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 60 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Female subjects between 25 and 60 years old
Who cannot join
- Pregnant or breastfeeding women
- Subjects who are allergic to the product
- Subjects with psoriasis or atopic dermatitis
- Subjects who have taken systemic corticosteroids within 2 weeks
- Subjects who have taken oral retinoid within 1 week
- Subjects with severe medical conditions, such as cardiovascular, liver, kidney, or hematopoietic system disorders
Show all 10Show fewer
- Subjects with tuberculosis
- Subjects with viral hepatitis or other infectious diseases
- Subjects with psychiatric disorders
- Subjects with external trauma or infections
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Taiwan1 site, 1 recruiting
- Recruiting
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City
Stephen Chu-Sung Hu, +886-7-3121101 ext. 6104, stephen@kmu.edu.tw
About this study
Official title: Clinical Evaluation of the Skincare Benefits of Kaempferol-Containing Masks
This is an open-label, two-arm study, which will evaluate the effects of Kaempferol-containing masks on skin biophysical properties
- Conditions
- Skin Biophysical Properties
- Being tested
- Kaempferol-containing facial mask, Hyaluronic acid-containing facial mask
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Kaempferol-containing facial maskOther
Kaempferol-containing facial mask
Hyaluronic acid-containing facial maskOther
Hyaluronic acid-containing facial mask
| Study group | Role | What they receive |
|---|---|---|
| Kaempferol-containing facial mask | Experimental | Not described Receives: Other: Kaempferol-containing facial mask |
| Hyaluronic acid-containing facial mask | Active comparator | Not described Receives: Other: Hyaluronic acid-containing facial mask |
What is being measured
The primary outcome is the main question the study is designed to answer.
Skin hydration
Measured: 12 weeks
Skin transepidermal water loss
Measured: 12 weeks
Skin coloration
Measured: 12 weeks
Skin elasticity
Measured: 12 weeks
Skin wrinkles
Measured: 12 weeks
Skin pores
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Mar 2026
- Study start9 Feb 2026
- Primary completionDec 2026 (estimated)
- Study completionMar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin Biophysical PropertiesStudies of the same condition, open and under way.
- More trials run by Kaohsiung Medical University Chung-Ho Memorial HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Collaborators
- Kaohsiung Municipal Hsiaokang Hospital
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07458334
- Sponsor's protocol ID
- S-113-20
- Status last verified
- Feb 2026
- First submitted
- 3 Mar 2026
- Last updated
- 9 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Evaluation of the Skincare Benefits of Kaempferol-Containing Masks
- ClinicalTrials.gov ID
- NCT07458334
- Acronym / sponsor ID
- S-113-20
- Conditions
- Skin Biophysical Properties
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Kaohsiung Medical University Chung-Ho Memorial HospitalUniversity, hospital or other
- Collaborators
- Kaohsiung Municipal Hsiaokang Hospital
- Study start
- 9 Feb 2026 (actual)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Mar 2027 (estimated)
- First posted
- 9 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is an open-label, two-arm study, which will evaluate the effects of Kaempferol-containing masks on skin biophysical properties
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Kaempferol-containing facial mask | Experimental | Other: Kaempferol-containing facial mask |
| Hyaluronic acid-containing facial mask | Active comparator | Other: Hyaluronic acid-containing facial mask |
Who may qualify
- Ages
- 25 to 60 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Female subjects between 25 and 60 years old
Key exclusion criteria (10 listed)
- Pregnant or breastfeeding women
- Subjects who are allergic to the product
- Subjects with psoriasis or atopic dermatitis
- Subjects who have taken systemic corticosteroids within 2 weeks
- Subjects who have taken oral retinoid within 1 week
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Kaempferol-containing facial maskKaempferol-containing facial mask | Other | Kaempferol-containing facial mask |
| Hyaluronic acid-containing facial maskHyaluronic acid-containing facial mask | Other | Hyaluronic acid-containing facial mask |
Primary outcome
Skin hydration
Time frame: 12 weeks
Skin transepidermal water loss
Time frame: 12 weeks
Skin coloration
Time frame: 12 weeks
Skin elasticity
Time frame: 12 weeks
Skin wrinkles
Time frame: 12 weeks
Skin pores
Time frame: 12 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Mar 2026.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Kaempferol-containing facial mask and Hyaluronic acid-containing facial mask in people with Skin Biophysical Properties, run by Kaohsiung Medical University Chung-Ho Memorial Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 9 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Stephen Chu-Sung Hu (+886-7-3121101 ext. 6104, stephen@kmu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Skin hydration (time frame: 12 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2026.